MYC oncogenes and human neoplastic disease
- 13 May 1999
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 18 (19) , 3004-3016
- https://doi.org/10.1038/sj.onc.1202746
Abstract
C-myc, N-myc and L-myc are the three members of the myc oncoprotein family whose role in the pathogenesis of many human neoplastic diseases has received wide empirical support. In this review, we first summarize data, derived mainly from non-clinical studies, indicating that these oncoproteins actually serve quite different roles in vivo. This concept necessarily lies at the heart of the basis for the observation that the deregulated expression of each MYC gene is reproducibly associated with only certain naturally occurring malignancies in humans and that these genes are not interchangeable with respect to their aberrant functional consequences. We also review evidence implicating each of the above MYC genes in specific neoplastic diseases and have attempted to identify unresolved questions which deserve further basic or clinical investigation. We have made every attempt to review those diseases for which significant and confirmatory evidence, based on studies with primary tumor material, exists to implicate MYC members in their causation and/or progression.Keywords
This publication has 175 references indexed in Scilit:
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- Point Mutations of the Mxil Gene are Rare in Prostate CancersThe Prostate, 1996
- C-myc oncogene expression in human melanoma and its relationship with tumour antigenicityEuropean Journal of Surgical Oncology, 1996
- N-MYC amplification, loss of heterozygosity on the short arm of chromosome 1 and DNA ploidy in retinoblastomaEuropean Journal Of Cancer, 1996
- Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: Correlation with steroid receptorsEuropean Journal Of Cancer, 1992
- c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapseEuropean Journal Of Cancer, 1992
- Expression in Non-Hodgkin's Lymphoma of thebcl-2 Protein Associated with the t(14;18) Chromosomal TranslocationNew England Journal of Medicine, 1988
- The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic miceCell, 1986
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985
- Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphomaNature, 1983